AUA CodingPlus Part Four (2023)
Availability
Retired
Cost
$0.00
Credit Offered
No Credit Offered

Ensure Your Practice Stays Ahead of the Curve in 2024 with AUA CodingPlus Part Four!

NOW AVAILABLE - NEW BONUS ON-DEMAND CONTENT FOR HCPCS ADD-ON CODE G2211 AND NEW CPT CODES!

A Can't-Miss Opportunity for Urology Providers, Practice Staff and Coders!

- This 90-minute session Streams live on Wednesday, November 29, 2023 from 12 - 1:30 pm Eastern Time -

* Approved for 1 CEU (live virtual only) *

Join urology s leading coding experts, Dr. Jonathan N. Rubenstein, and Edna R. Maldonado, on November 29, 2023 for the exclusive AUA CodingPlus Part Four (2023) to receive an in-depth exploration of the coding & reimbursement updates taking effect on January 1, 2024.

Key Topics Include:

  • 2024 Medicare Physician Fee Schedule (MPFS) Final Rule Major Impacts on the field of urology explored
  • Evaluation & Management (E/M) updates Latest updates and instructions for practical implementation discussed
  • 2024 CPT Codes and RUC Valuations New/updated CPT codes and valuations of interest to urology explained

Live Virtual and On-Demand Content Included! Live Virtual Approved for 1 CEU!


Top Five Reasons AUA CodingPlus Part Four is a MUST ATTEND:

  1. Get Ahead for 2024: Equip your urology practice for a successful start in 2024.
  2. Tap into Expertise: Learn from AUA's industry leading experts and gain valuable insights.
  3. Optimize Reimbursements: Stay up to date with the latest CPT codes and Evaluation & Management updates to enhance your reimbursement strategies in 2024.
  4. Enhance Efficiency: Adapt your practice swiftly for improved operational efficiency in the upcoming year.
  5. Stay Competitive: Be among the first to receive vital 2024 updates to maintain your competitive edge.

Secure your spot by registering today!



Course Registration Fees (Includes Live Virtual and On-Demand* Content)

  • REGISTER NOW and take advantage of this essential coding update!

  • Want even more coding education? You can register for the AUA CodingPlus Bundle here!

AUA CodingPlus Part Four (2023)

Part Four (2023) Only

Member/PMN

$79

Non-member

$119

*Note: On-Demand recordings are non-CME and non-CEU.

  • Practice Administrators
  • Practice Managers
  • Coders
  • Physicians
  • Anyone involved with the day-to-day management of urologic practice

At the conclusion of this activity, the learner will:

  1. Demonstrate a thorough comprehension of the major impacts of the 2024 Medicare Physician Fee Schedule (MPFS) Final Rule on the field of urology.
  2. Proficiently navigate and apply the latest updates to the Current Procedural Terminology (CPT) and Evaluation & Management (E/M) coding systems.
  3. Recognize the implications for urological services of the 2024 Relative Value Unit (RVU) and Resource-Based Relative Value Scale (RBRVS) valuations and strategically adjust coding and documentation practices to ensure equitable reimbursement while maintaining compliance with regulations.

Education Council Disclosures

Education Council Disclosures.pdf

COI Review Work Group Disclosures

COI Review Work Group Disclosures.pdf

For a full listing of all faculty disclosures, please visit AUA CodingPlus (2023) and click on the "Faculty" tab.

AUA Office of Education Staff has nothing to disclose.

All relevant financial relationships have been mitigated.

AUA ACCREDITATION INFORMATION

ACCREDITATION:

The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION:

The American Urological Association designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

OTHER LEARNERS:

The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 CreditsTM.

EVIDENCE BASED CONTENT:

It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

AUA DISCLOSURE POLICY:

All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider all financial relationships with any commercial interest during the previous 24 months. The AUA must determine if the individual s relationships may influence the educational content and mitigate any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

MITIGATION OF IDENTIFIED CONFLICT OF INTEREST:

All disclosures will be reviewed by the AUA Conflict of Interest (COI) Review Work Group Chair and/or Vice Chair for identification of conflicts of interest. The AUA COI Review Work Group, working with Office of Education staff, will document the mechanism(s) for management and mitigation of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to mitigate conflict of interest:

  • Peer review for valid, evidence-based content by the AUA COI Review Work Group.
  • Attestation that clinical recommendations are evidence-based and free of commercial bias.
  • Introduction of a debate format (point-counterpoint)
  • Inclusion of moderated panel discussion with unbiased moderator
  • Publication of a parallel or rebuttal article for an article that is felt to be biased
  • Divestiture of the relationship by faculty
  • Recusal from controlling relevant aspects of planning
  • Selection of alternative faculty for specific topic

OFF-LABEL OR UNAPPROVED USE OF DRUGS OR DEVICES:

The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.